DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,199 | -8.3% | 8,863 | -11.3% | 0.76% | -1.0% |
| Q2 2023 | $2,398 | -6.0% | 9,993 | -1.2% | 0.77% | -14.7% |
| Q1 2023 | $2,550 | -99.9% | 10,118 | -4.0% | 0.91% | -17.3% |
| Q3 2022 | $2,721,000 | +2.7% | 10,535 | +0.8% | 1.10% | +7.6% |
| Q2 2022 | $2,649,000 | -19.7% | 10,450 | -7.0% | 1.02% | +9.1% |
| Q1 2022 | $3,297,000 | -14.7% | 11,240 | -4.3% | 0.93% | -5.2% |
| Q4 2021 | $3,865,000 | +7.3% | 11,748 | -0.7% | 0.98% | -2.9% |
| Q3 2021 | $3,601,000 | +14.7% | 11,827 | +1.1% | 1.01% | +14.2% |
| Q2 2021 | $3,139,000 | +19.5% | 11,697 | +0.3% | 0.89% | 0.0% |
| Q1 2021 | $2,626,000 | -8.8% | 11,665 | -10.0% | 0.89% | -14.4% |
| Q4 2020 | $2,879,000 | -19.3% | 12,962 | -21.8% | 1.04% | -24.4% |
| Q3 2020 | $3,569,000 | +10.0% | 16,573 | -9.7% | 1.37% | -7.3% |
| Q2 2020 | $3,244,000 | +53.7% | 18,347 | +20.4% | 1.48% | +4.4% |
| Q1 2020 | $2,110,000 | -57.5% | 15,242 | -52.8% | 1.42% | -13.7% |
| Q4 2019 | $4,960,000 | +2.2% | 32,317 | -3.9% | 1.64% | -14.5% |
| Q3 2019 | $4,855,000 | -14.5% | 33,612 | -15.4% | 1.92% | -13.5% |
| Q2 2019 | $5,676,000 | +5.6% | 39,712 | -2.5% | 2.22% | -1.4% |
| Q1 2019 | $5,375,000 | +25.4% | 40,712 | -2.0% | 2.25% | +0.5% |
| Q4 2018 | $4,285,000 | -8.0% | 41,557 | -3.0% | 2.24% | +23.5% |
| Q3 2018 | $4,656,000 | +4.0% | 42,852 | -5.6% | 1.81% | -3.3% |
| Q2 2018 | $4,477,000 | -4.0% | 45,372 | -4.7% | 1.87% | -11.7% |
| Q1 2018 | $4,663,000 | -2.6% | 47,622 | -7.7% | 2.12% | -5.3% |
| Q4 2017 | $4,788,000 | -2.5% | 51,582 | -9.9% | 2.24% | +5.0% |
| Q3 2017 | $4,913,000 | +2.9% | 57,272 | +1.3% | 2.14% | +3.8% |
| Q2 2017 | $4,773,000 | -6.2% | 56,562 | -4.9% | 2.06% | -10.4% |
| Q1 2017 | $5,086,000 | +4.8% | 59,462 | -4.7% | 2.30% | +7.9% |
| Q4 2016 | $4,855,000 | +27.3% | 62,372 | +28.2% | 2.13% | +25.7% |
| Q3 2016 | $3,815,000 | +16.8% | 48,667 | +50.5% | 1.69% | +16.2% |
| Q2 2016 | $3,265,000 | – | 32,330 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |